Su C, Chai H, See Y, Kumar RS. GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF SGLT2 INHIBITORS (EMPAGLIFLOZIN 25 MG, EMPAGLIFLOZIN 12.5 MG AND DAPAGLIFLOZIN 10 MG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: A SINGLE CENTRE STUDY. J ASEAN Fed Endocr Soc [Internet]. 2024Jul.17 [cited 2024Jul.20];39(S1):25. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/4457